PacBio Q1 rev flat at $37.2M; consumable record but instrument miss; FY26 guidance $165-175M

PACIFIC BIOSCIENCES OF CALIFORNIA, INC.

2026-Q1 EPS reported -$0.03 revenue$37,178,000

Q1 revenue $37.2M flat YoY; consumable record $21.8M (+8% YoY), instrument revenue $9.7M (-12% YoY) below expectations.
GAAP net loss $8.3M ($0.03/sh) vs $426.1M loss ($1.44/sh) in Q1 2025 (incl. restructuring); non-GAAP loss $35.9M ($0.12/sh).
Full year 2026 revenue guidance $165M-$175M; cash $276M after $48.1M net from short-read asset sale.
SPRQ-Nx beta to broad Revio launch in May; Basecamp Research project for ~100K samples selected PacBio.
EMEA revenue +17% YoY; non-GAAP gross margin 37% vs 40% on component costs and promotions.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

PACIFIC BIOSCIENCES OF CALIFORNIA, INC. reported for its first fiscal quarter ended March 31, 2026 results: revenue $37.2, net income GAAP net loss for the first quarter of 2026 was $8.3 million, EPS GAAP net loss per share for the first quarter of 2026 was $0.03. Guidance reaffirmed.

Period: for its first fiscal quarter ended March 31, 2026
Revenue: $37.2
Net income: GAAP net loss for the first quarter of 2026 was $8.3 million
EPS: GAAP net loss per share for the first quarter of 2026 was $0.03
Guidance: reaffirmed
Result: reported results

Exact text from the filing

which has the potential to produce the largest and most diverse high-fidelity metagenomic dataset in the world." First quarter results: Q1 2026 Q1 2025 Revenue (in millions) $37.2 $37.2 Consumable revenue (in millions) $21.8 $20.1 Instrument revenue (in millions) $9.7 $11.0 Service and other revenue (in millions) $5.6 $6.0 Revio TM system placements 15 12

View on SEC.gov

Browse all earnings releases →

PACIFIC BIOSCIENCES OF CALIFORNIA, INC. filing history →

Source: SEC EDGAR

accession 0001299130-26-000076

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.